Tag Archives: AstraZeneca

Four men develop life-threatening condition after receiving AstraZeneca jab – symptoms

Dr Christopher Allen, a clinical neuroscientist at Nottingham University, who wrote the article, acknowledged that the jury is out at this stage whether the jab caused the deadly syndrome and it could merely be association. But it demonstrates the need for “robust post-vaccination surveillance” nonetheless, he said. He stressed that the current crop of vaccines… Read More: Four men develop life-threatening condition after receiving AstraZeneca jab –… »

‘Very little excuse’ to continue to use AstraZeneca in Canada: infectious diseases specialist

Breadcrumb Trail Links News Health Canada It’s time to halt AstraZeneca shots in Canada, except for people 40 or older in hotspots, says Andrew Morris, a doctor on Ontario’s COVID-19 science advisory table Author of the article: Sharon Kirkey Publishing date: May 11, 2021  •  44 minutes ago  •  6 minute read  •  145 Comments Empty… Read More: ‘Very little excuse’ to continue to use AstraZeneca in Canada:… »

AstraZeneca Vaccine and Blood Clots: What Is Known So Far

The Coronavirus Outbreak liveLatest Updates Maps and Cases Risk Near You Who Can Get Vaccinated? Vaccine Questions Advertisement Continue reading the main story Supported by Continue reading the main story AstraZeneca Vaccine and Blood Clots: What Is Known So Far In rare cases, an immune reaction has led to antibodies that caused a serious clotting… Read More: AstraZeneca Vaccine and Blood Clots: What Is Known So Far »

Will Canada approve a first-dose-first strategy now that AstraZeneca has been approved?

Breadcrumb Trail Links News Health Canada The U.K.’s controversial strategy to space vaccine doses up to three months apart could see everyone offered a first dose by end of July — months sooner than Canada Author of the article: Sharon Kirkey Publishing date: Feb 26, 2021  •  2 days ago  •  4 minute read  •  68… Read More: Will Canada approve a first-dose-first strategy now that AstraZeneca has… »